The designation allows pharmacists to substitute it for Humira without prescriber approval (per state law), which expands ...

The rebrand creates a platform that is expected enhance the way life sciences companies bring their therapies to market.

Just as importantly, Serialization 2.0 enables better decision-making across the enterprise by unlocking data trapped in ...

As this medical approach continues to become more widely adopted, the industry must adapt to help provide precise, compliant, ...

In the fourth part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, ...

The partnership is centered around cutting cold chain costs and emissions with smart packaging and carbon-neutral same-day ...

The telehealth site will welcome its own small-dose, compounded version of semaglutide, which mimics the function of a GLP-1.

Addressing drug shortages requires the industry to embrace innovative advanced manufacturing processes underpinned by ...

In a recent interview with Applied Clinical Trials, Michel van Harten, MD, CEO of myTomorrows, discussed how AI is transforming clinical trials by reducing costs, accelerating timelines, and enhancing ...

In an interview with Applied Clinical Trials, Michel van Harten, MD, CEO of myTomorrows, explained how AI can help address clinical trial diversity and access challenges by reducing physician workload ...

In an exclusive sit-down with Pharma Commerce, Anne Cassity, senior vice president of government affairs for the National ...

In the final part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, describes best practices for balancing long-term pipeline sustainability with ...